Citadel Group — Major Shareholding Notification 2023

Apr 17, 2023

National Storage Mechanism | Additional information

RNS Number : 4751W

Citadel Group

17 April 2023

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser	Citadel Group
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree	HORIZON THERAPEUTICS PLC
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)	N/A
(e)   Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	14 April 2023
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	Common Stock ISIN IE00BQPVQZ61
	Interests		Short positions
Number	%	Number	%
(1)   Relevant securities owned and/or controlled	3,626,690	1.58	144	0.00
(2)   Cash-settled derivatives	0	0.00	0	0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell	100,000	0.04	50,000	0.02
Total	3,726,690	1.63	50,144	0.02

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit (Note 5)
Common	Buy Transaction	400	111.0000 USD
Common	Buy Transaction	500	111.5500 USD
Common	Buy Transaction	361	111.6000 USD
Common	Buy Transaction	562	111.6228 USD
Common	Buy Transaction	108	111.6228 USD
Common	Buy Transaction	230	111.6228 USD
Common	Buy Transaction	100	111.7000 USD
Common	Buy Transaction	18	111.7317 USD
Common	Buy Transaction	5	111.7330 USD
Common	Buy Transaction	1,604	111.7618 USD
Common	Buy Transaction	4,167	111.7630 USD
Common	Buy Transaction	848	111.7656 USD
Common	Buy Transaction	126	111.8388 USD
Common	Buy Transaction	620	111.8396 USD
Common	Buy Transaction	242	111.8408 USD
Common	Buy Transaction	51	111.8495 USD
Common	Buy Transaction	251	111.8509 USD
Common	Buy Transaction	98	111.8531 USD
Common	Buy Transaction	996	111.8582 USD
Common	Buy Transaction	811	111.8585 USD
Common	Buy Transaction	2,133	111.8593 USD
Common	Buy Transaction	552	111.8593 USD
Common	Buy Transaction	2,645	111.8594 USD
Common	Buy Transaction	439	111.8616 USD
Common	Buy Transaction	1,160	111.8654 USD
Common	Buy Transaction	3,049	111.8655 USD
Common	Buy Transaction	633	111.8659 USD
Common	Buy Transaction	1,059	111.8671 USD
Common	Buy Transaction	3,220	111.8673 USD
Common	Buy Transaction	134	111.8685 USD
Common	Buy Transaction	8,932	111.8689 USD
Common	Buy Transaction	2,759	111.8692 USD
Common	Buy Transaction	8,367	111.8699 USD
Common	Buy Transaction	563	111.8723 USD
Common	Buy Transaction	1,720	111.8730 USD
Common	Buy Transaction	339	111.8743 USD
Common	Buy Transaction	69	111.8785 USD
Common	Buy Transaction	262	111.8855 USD
Common	Buy Transaction	12,951	111.8981 USD
Common	Buy Transaction	768	111.9204 USD
Common	Buy Transaction	507	111.9736 USD
Common	Buy Transaction	1,323	111.9738 USD
Common	Buy Transaction	271	111.9748 USD
Common	Buy Transaction	200	112.0050 USD
Common	Buy Transaction	200	112.0100 USD
Common	Buy Transaction	100	112.0450 USD
Common	Buy Transaction	4,303	112.0658 USD
Common	Buy Transaction	496	112.0672 USD
Common	Buy Transaction	200	112.0900 USD
Common	Buy Transaction	400	112.0950 USD
Common	DVP Transaction	532	111.6000 USD
Common	DVP Transaction	66	111.6100 USD
Common	DVP Transaction	134	111.6200 USD
Common	DVP Transaction	300	111.6300 USD
Common	DVP Transaction	300	111.6400 USD
Common	DVP Transaction	887	111.6500 USD
Common	DVP Transaction	263	111.6550 USD
Common	DVP Transaction	947	111.6800 USD
Common	DVP Transaction	2	111.6900 USD
Common	RVP Transaction	532	111.6000 USD
Common	RVP Transaction	66	111.6100 USD
Common	RVP Transaction	134	111.6200 USD
Common	RVP Transaction	300	111.6300 USD
Common	RVP Transaction	300	111.6400 USD
Common	RVP Transaction	887	111.6500 USD
Common	RVP Transaction	263	111.6550 USD
Common	RVP Transaction	947	111.6800 USD
Common	RVP Transaction	2	111.6900 USD
Common	Sell Transaction	100	111.3800 USD
Common	Sell Transaction	68	111.4432 USD
Common	Sell Transaction	28	111.4525 USD
Common	Sell Transaction	215	111.4638 USD
Common	Sell Transaction	15	111.4653 USD
Common	Sell Transaction	89	111.4744 USD
Common	Sell Transaction	47	111.4806 USD
Common	Sell Transaction	645	111.5095 USD
Common	Sell Transaction	108	111.5100 USD
Common	Sell Transaction	171	111.6000 USD
Common	Sell Transaction	15	111.6500 USD
Common	Sell Transaction	339	111.6502 USD
Common	Sell Transaction	1,250	111.7164 USD
Common	Sell Transaction	15,297	111.7415 USD
Common	Sell Transaction	134	111.7704 USD
Common	Sell Transaction	55	111.7705 USD
Common	Sell Transaction	29	111.7716 USD
Common	Sell Transaction	100	111.8400 USD
Common	Sell Transaction	903	111.8436 USD
Common	Sell Transaction	372	111.8440 USD
Common	Sell Transaction	195	111.8446 USD
Common	Sell Transaction	27	111.8500 USD
Common	Sell Transaction	93	111.8644 USD
Common	Sell Transaction	24	111.8721 USD
Common	Sell Transaction	94	111.8730 USD
Common	Sell Transaction	274	111.8731 USD
Common	Sell Transaction	57	111.8732 USD
Common	Sell Transaction	4	111.8738 USD
Common	Sell Transaction	89	111.8900 USD
Common	Sell Transaction	23	111.8915 USD
Common	Sell Transaction	210	111.8936 USD
Common	Sell Transaction	1,017	111.8938 USD
Common	Sell Transaction	347	111.8957 USD
Common	Sell Transaction	299	111.9412 USD
Common	Sell Transaction	263	111.9462 USD
Common	Sell Transaction	4	111.9463 USD
Common	Sell Transaction	251	111.9684 USD
Common	Sell Transaction	109	111.9694 USD
Common	Sell Transaction	65	111.9738 USD
Common	Sell Transaction	49	111.9767 USD
Common	Sell Transaction	400	111.9775 USD
Common	Sell Transaction	97	111.9785 USD
Common	Sell Transaction	242	111.9789 USD
Common	Sell Transaction	100	111.9900 USD
Common	Sell Transaction	125,000	111.9974 USD
Common	Sell Transaction	100	112.0000 USD
Common	Sell Transaction	20	112.0065 USD
Common	Sell Transaction	375	112.0212 USD
Common	Sell Transaction	1,824	112.0220 USD
Common	Sell Transaction	656	112.0239 USD
Common	Sell Transaction	6	112.0400 USD
Common	Sell Transaction	721	112.0500 USD

Ap29

(b)           Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position	Number of reference securities (Note 6)	Price per unit (Note 5)

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 6)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)           Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant security	Nature of dealing e.g. subscription, conversion, exercise	Details	Price per unit (if applicable) (Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None

(c)           Attachments

Is a Supplemental Form 8 attached?	NO

Date of disclosure	17 April 2023
Contact name	Paula Sharp
Telephone number	020 7645 9700

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap31

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1.             KEY INFORMATION

Full name of person making disclosure:	Citadel Group
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	HORIZON THERAPEUTICS PLC

2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date
Common	Put Option	Sold	50,000	100 USD	American	18/08/2023
Common	Call Option	Purchased	50,000	115 USD	American	18/08/2023
Common	Put Option	Purchased	- 50,000	80 USD	American	18/08/2023

3.             AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEALLXFEPDEFA